David J. Rog

Salford, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 59 publications

EQUITY-MS: evaluating the quality of investigation and treatment of multiple sclerosis using data from five specialist neurology centres in the UK-study protocol.

EQUITY-MS: evaluating the quality of investigation and treatment of multiple sclerosis using data from five specialist neurology centres in the UK-study protocol.

Journal: BMJ open

Published: September 03, 2026

UK consensus on pregnancy in multiple sclerosis: An update to 'Association of British Neurologists' guidance.

UK consensus on pregnancy in multiple sclerosis: An update to 'Association of British Neurologists' guidance.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: July 03, 2026

Evaluating the effectiveness of simvastatin in slowing the progression of disability in secondary progressive multiple sclerosis: a synopsis of MS-STAT2, a multicentre, randomised controlled, double-blind, phase 3 clinical trial.

Evaluating the effectiveness of simvastatin in slowing the progression of disability in secondary progressive multiple sclerosis: a synopsis of MS-STAT2, a multicentre, randomised controlled, double-blind, phase 3 clinical trial.

Journal: Health technology assessment (Winchester, England)

Published: June 29, 2026

Genetic Determinants of Multiple Sclerosis Susceptibility in People From Diverse Ancestral Backgrounds.

Genetic Determinants of Multiple Sclerosis Susceptibility in People From Diverse Ancestral Backgrounds.

Journal: Neurology

Published: March 06, 2026

Health inequalities in outpatient neurological conditions across a large UK urban population: a retrospective observational study using automated coding.

Health inequalities in outpatient neurological conditions across a large UK urban population: a retrospective observational study using automated coding.

Journal: BMJ neurology open

Published: January 06, 2026

Fatigue prevalence, interactions with associated symptoms and longitudinal changes in those with multiple sclerosis: Insights from the TONiC study.

Fatigue prevalence, interactions with associated symptoms and longitudinal changes in those with multiple sclerosis: Insights from the TONiC study.

Journal: Journal of the neurological sciences

Published: December 01, 2025

Employment status in people with multiple sclerosis: Profile, dynamic changes and determinants over time.

Employment status in people with multiple sclerosis: Profile, dynamic changes and determinants over time.

Journal: Multiple sclerosis and related disorders

Published: November 04, 2025

Effect of repurposed simvastatin on disability progression in secondary progressive multiple sclerosis (MS-STAT2): a phase 3, randomised, double-blind, placebo-controlled trial.

Effect of repurposed simvastatin on disability progression in secondary progressive multiple sclerosis (MS-STAT2): a phase 3, randomised, double-blind, placebo-controlled trial.

Journal: Lancet (London, England)

Published: March 23, 2025

Impact of relative deprivation and ethnicity on the incidence rate of amyotrophic lateral sclerosis.

Impact of relative deprivation and ethnicity on the incidence rate of amyotrophic lateral sclerosis.

Journal: Amyotrophic lateral sclerosis & frontotemporal degeneration

Published: February 19, 2025

Assisted reproduction technology in multiple sclerosis.

Assisted reproduction technology in multiple sclerosis.

Journal: Practical neurology

Published: January 08, 2025

Physical and psychological aspects of multiple sclerosis: Revisiting the Multiple Sclerosis Impact Scale (MSIS-29).

Physical and psychological aspects of multiple sclerosis: Revisiting the Multiple Sclerosis Impact Scale (MSIS-29).

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: October 30, 2024

Evaluating the effectiveness of simvastatin in slowing the progression of disability in secondary progressive multiple sclerosis (MS-STAT2): protocol for a multicentre, randomised controlled, double-blind, phase 3 clinical trial in the UK.

Evaluating the effectiveness of simvastatin in slowing the progression of disability in secondary progressive multiple sclerosis (MS-STAT2): protocol for a multicentre, randomised controlled, double-blind, phase 3 clinical trial in the UK.

Journal: BMJ open

Published: September 16, 2024

Showing 1-12 of 59

Last Updated: 09/26/2026